Vita Life Sciences Limited (ASX:VLS)
Australia · Delayed Price · Currency is AUD 2.590
+0.070 (2.78%)
At close: Mar 25, 2026
Vita Life Sciences Market Cap
Vita Life Sciences has a market cap or net worth of 137.39 million as of March 24, 2026. Its market cap has increased by 28.88% in one year.
Market Cap
137.39M
Enterprise Value
104.12M
Revenue
93.27M
Ranking
n/a
PE Ratio
13.73
Stock Price
2.59
Market Cap Chart
Since August 23, 2007, Vita Life Sciences's market cap has increased from 2.18M to 137.39M, an increase of 6,194.31%. That is a compound annual growth rate of 24.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 25, 2026 | 141.20M | 0.20% |
| Dec 31, 2025 | 140.92M | 26.53% |
| Dec 31, 2024 | 111.37M | 16.19% |
| Dec 27, 2023 | 95.85M | 25.15% |
| Dec 21, 2022 | 76.59M | -26.95% |
| Dec 31, 2021 | 104.86M | 93.88% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Syntara | 49.02M |
| Medical Developments International | 42.25M |
| Little Green Pharma | 28.14M |
| Vitura Health | 26.51M |
| Peak Processing | 18.57M |
| IDT Australia | 18.38M |
| Epsilon Healthcare | 8.56M |
| Cann Group | 7.98M |